DIAMOND Research Programme
@diamond-derx.bsky.social
Innovating Methods | Advancing Deprescribing
Based at RCSI (https://bsky.app/profile/rcsi.bsky.social), led by Prof Frank Moriarty (@frankmoriarty.bsky.social) and funded by Wellcome.
Find out more about our work here: https://diamond-deprescribing.eu/
Based at RCSI (https://bsky.app/profile/rcsi.bsky.social), led by Prof Frank Moriarty (@frankmoriarty.bsky.social) and funded by Wellcome.
Find out more about our work here: https://diamond-deprescribing.eu/
Pinned
#DePhaRM group and @frankmoriarty.bsky.social were delighted to welcome Dr Justin Turner (@optimisingrxuse.bsky.social) for today’s @rcsi.bsky.social PBS seminar. He gave an inspiring look at Pharmacist-led #deprescribing in real-world care through the SaferMedsNL initiative. #ImplementationScience
It's World Benzodiazepine Awareness Day! 💊
For the UN Decade of Healthy Ageing, the WHO’s new monitoring framework recognises safe medication use as a cornerstone of ageing well, including indicators for older persons:
🔹Prescribed benzodiazepines for >1 year
🔹Taking 5+ medications daily
1/n
For the UN Decade of Healthy Ageing, the WHO’s new monitoring framework recognises safe medication use as a cornerstone of ageing well, including indicators for older persons:
🔹Prescribed benzodiazepines for >1 year
🔹Taking 5+ medications daily
1/n
July 11, 2025 at 12:03 PM
It's World Benzodiazepine Awareness Day! 💊
For the UN Decade of Healthy Ageing, the WHO’s new monitoring framework recognises safe medication use as a cornerstone of ageing well, including indicators for older persons:
🔹Prescribed benzodiazepines for >1 year
🔹Taking 5+ medications daily
1/n
For the UN Decade of Healthy Ageing, the WHO’s new monitoring framework recognises safe medication use as a cornerstone of ageing well, including indicators for older persons:
🔹Prescribed benzodiazepines for >1 year
🔹Taking 5+ medications daily
1/n
Reposted by DIAMOND Research Programme
Just ten days left to apply for this Research Fellow position, focused on pharmacoepidemiology and deprescribing.
More information about the DIAMOND programme available at: diamond-deprescribing.eu
Full job description here (deadline July 7th): my.corehr.com/pls/rcsirecr...
More information about the DIAMOND programme available at: diamond-deprescribing.eu
Full job description here (deadline July 7th): my.corehr.com/pls/rcsirecr...
June 27, 2025 at 9:28 AM
Just ten days left to apply for this Research Fellow position, focused on pharmacoepidemiology and deprescribing.
More information about the DIAMOND programme available at: diamond-deprescribing.eu
Full job description here (deadline July 7th): my.corehr.com/pls/rcsirecr...
More information about the DIAMOND programme available at: diamond-deprescribing.eu
Full job description here (deadline July 7th): my.corehr.com/pls/rcsirecr...
Reposted by DIAMOND Research Programme
We work on developing methods to better support research on deprescribing and to ultimately improve medicines optimisation.
You can find out more about the DIAMOND research programme on our website or LinkedIn profile:
diamond-deprescribing.eu
www.linkedin.com/company/diamond-derx/
You can find out more about the DIAMOND research programme on our website or LinkedIn profile:
diamond-deprescribing.eu
www.linkedin.com/company/diamond-derx/
Home
DIAMOND is an ambitious Wellcome-funded programme of research that aims to develop and advance novel methods for researching deprescribing by harnessing big data.
diamond-deprescribing.eu
June 23, 2025 at 2:16 PM
We work on developing methods to better support research on deprescribing and to ultimately improve medicines optimisation.
You can find out more about the DIAMOND research programme on our website or LinkedIn profile:
diamond-deprescribing.eu
www.linkedin.com/company/diamond-derx/
You can find out more about the DIAMOND research programme on our website or LinkedIn profile:
diamond-deprescribing.eu
www.linkedin.com/company/diamond-derx/
Reposted by DIAMOND Research Programme
Interested in medications, data and deprescribing? We're looking for a Research Fellow to join the @diamond-derx.bsky.social team @rcsi.bsky.social!
If you're an experienced researcher interested in harnessing routine healthcare data, please apply by 7 July: my.corehr.com/pls/rcsirecr...
If you're an experienced researcher interested in harnessing routine healthcare data, please apply by 7 July: my.corehr.com/pls/rcsirecr...
June 23, 2025 at 2:14 PM
Interested in medications, data and deprescribing? We're looking for a Research Fellow to join the @diamond-derx.bsky.social team @rcsi.bsky.social!
If you're an experienced researcher interested in harnessing routine healthcare data, please apply by 7 July: my.corehr.com/pls/rcsirecr...
If you're an experienced researcher interested in harnessing routine healthcare data, please apply by 7 July: my.corehr.com/pls/rcsirecr...
Reposted by DIAMOND Research Programme
This new qualitative study showcased that older adults’ readiness for deprescribing is influenced by their medication valuation, decision-making preferences, and openness to change. A combination of these attributes can be used to define 5 distinct patient types.
www.annfammed.org/content/23/3...
www.annfammed.org/content/23/3...
June 2, 2025 at 3:06 PM
This new qualitative study showcased that older adults’ readiness for deprescribing is influenced by their medication valuation, decision-making preferences, and openness to change. A combination of these attributes can be used to define 5 distinct patient types.
www.annfammed.org/content/23/3...
www.annfammed.org/content/23/3...
Reposted by DIAMOND Research Programme
🚨ICYMI - Updated Cochrane #SystematicReview:
Withdrawal of antihypertensive drugs in older people 💊
doi.org/10.1002/1465...
"Future research should focus on populations with the greatest uncertainty of the benefit:risk ratio"
#CochraneEvidence #bloodpressure #deprescribing
Withdrawal of antihypertensive drugs in older people 💊
doi.org/10.1002/1465...
"Future research should focus on populations with the greatest uncertainty of the benefit:risk ratio"
#CochraneEvidence #bloodpressure #deprescribing
June 10, 2025 at 8:11 PM
🚨ICYMI - Updated Cochrane #SystematicReview:
Withdrawal of antihypertensive drugs in older people 💊
doi.org/10.1002/1465...
"Future research should focus on populations with the greatest uncertainty of the benefit:risk ratio"
#CochraneEvidence #bloodpressure #deprescribing
Withdrawal of antihypertensive drugs in older people 💊
doi.org/10.1002/1465...
"Future research should focus on populations with the greatest uncertainty of the benefit:risk ratio"
#CochraneEvidence #bloodpressure #deprescribing
#DePhaRM group and @frankmoriarty.bsky.social were delighted to welcome Dr Justin Turner (@optimisingrxuse.bsky.social) for today’s @rcsi.bsky.social PBS seminar. He gave an inspiring look at Pharmacist-led #deprescribing in real-world care through the SaferMedsNL initiative. #ImplementationScience
June 20, 2025 at 3:57 PM
#DePhaRM group and @frankmoriarty.bsky.social were delighted to welcome Dr Justin Turner (@optimisingrxuse.bsky.social) for today’s @rcsi.bsky.social PBS seminar. He gave an inspiring look at Pharmacist-led #deprescribing in real-world care through the SaferMedsNL initiative. #ImplementationScience
At DIAMOND, we care about doing transparency and reproducibility - not just saying it.
We recently read @antonpottegaard.bsky.social’s “10 Must-Read Papers on Transparency in Pharmacoepi” and turned recommendations into action. 🧵
We recently read @antonpottegaard.bsky.social’s “10 Must-Read Papers on Transparency in Pharmacoepi” and turned recommendations into action. 🧵
June 5, 2025 at 4:28 PM
At DIAMOND, we care about doing transparency and reproducibility - not just saying it.
We recently read @antonpottegaard.bsky.social’s “10 Must-Read Papers on Transparency in Pharmacoepi” and turned recommendations into action. 🧵
We recently read @antonpottegaard.bsky.social’s “10 Must-Read Papers on Transparency in Pharmacoepi” and turned recommendations into action. 🧵
DIAMOND WP2 is exploring how simulation can support target trial emulation in deprescribing research. We recently conducted a review of simulation studies - 📢preprint now here: doi.org/10.1101/2025....
We also attended a brilliant simulation course led by Tim Morris, UCL: tinyurl.com/UCLSimTraining
We also attended a brilliant simulation course led by Tim Morris, UCL: tinyurl.com/UCLSimTraining
Pharmacoepidemiology simulation study practices: A methodological review
Purpose Simulation studies are used in pharmacoepidemiology for evaluating inferential methods in a controlled setting, whereby a known data-generating mechanism allows evaluation of the performance o...
doi.org
May 29, 2025 at 3:06 PM
DIAMOND WP2 is exploring how simulation can support target trial emulation in deprescribing research. We recently conducted a review of simulation studies - 📢preprint now here: doi.org/10.1101/2025....
We also attended a brilliant simulation course led by Tim Morris, UCL: tinyurl.com/UCLSimTraining
We also attended a brilliant simulation course led by Tim Morris, UCL: tinyurl.com/UCLSimTraining
Reposted by DIAMOND Research Programme
Last few days to apply for this funded PhD on deprescribing in chronic kidney disease, closes on Monday 2nd June!
We're looking for a PhD scholar for a @hrbireland.bsky.social funded 4-year project focused on prescribing and deprescribing in chronic kidney disease, based at @rcsi.bsky.social.
If interested in pharmacoepi/health services research, please apply (D/L 2nd June): www.rcsi.com/dublin/resea...
If interested in pharmacoepi/health services research, please apply (D/L 2nd June): www.rcsi.com/dublin/resea...
Enhancing prescribing In chronic kidney disease in primary care (EPIC)
The overall research project aims to develop a comprehensive set of indicators to guide medicines optimisation and deprescribing in people with CKD in primary care. More ...
www.rcsi.com
May 28, 2025 at 12:11 PM
Last few days to apply for this funded PhD on deprescribing in chronic kidney disease, closes on Monday 2nd June!
Reposted by DIAMOND Research Programme
TOMORROW: Don't miss the next International Deprescribing Journal Club with Dr. Karen Voigt, hosted by the German Deprescribing Network!
Register here: us02web.zoom.us/meeting/regi...
Register here: us02web.zoom.us/meeting/regi...
The next International Deprescribing Journal Club is May 23rd!
The German Deprescribing Network will be hosting Dr. Karen Voigt, who will discuss facilitators & barriers to #deprescribing levothyroxine, and strategies to engage patients & physicians.
Register here: us02web.zoom.us/meeting/regi...
The German Deprescribing Network will be hosting Dr. Karen Voigt, who will discuss facilitators & barriers to #deprescribing levothyroxine, and strategies to engage patients & physicians.
Register here: us02web.zoom.us/meeting/regi...
May 22, 2025 at 2:32 PM
TOMORROW: Don't miss the next International Deprescribing Journal Club with Dr. Karen Voigt, hosted by the German Deprescribing Network!
Register here: us02web.zoom.us/meeting/regi...
Register here: us02web.zoom.us/meeting/regi...
Reposted by DIAMOND Research Programme
Searching for evidence-based literature on the safe and quality use of medications in older adults? 📖
Don't miss the new #Polypharmacy and #Geriatrics book from Nagham Ailabouni, including must-read chapters from global #deprescribing leaders! 🌎
buff.ly/6NXSdxb
Don't miss the new #Polypharmacy and #Geriatrics book from Nagham Ailabouni, including must-read chapters from global #deprescribing leaders! 🌎
buff.ly/6NXSdxb
Polypharmacy and Geriatrics
This book sheds light on quality use of medicines in older people, especially those who may have several comorbidities.
link.springer.com
May 17, 2025 at 4:01 PM
Searching for evidence-based literature on the safe and quality use of medications in older adults? 📖
Don't miss the new #Polypharmacy and #Geriatrics book from Nagham Ailabouni, including must-read chapters from global #deprescribing leaders! 🌎
buff.ly/6NXSdxb
Don't miss the new #Polypharmacy and #Geriatrics book from Nagham Ailabouni, including must-read chapters from global #deprescribing leaders! 🌎
buff.ly/6NXSdxb
Reposted by DIAMOND Research Programme
Pharmacoepidemiology is at a crossroads 🛣️
Discover how a proposed transparency statement can advance openness and reproducibility in research in our latest guest blog post from @antonpottegaard.bsky.social and @shirleywangv.bsky.social.
#Pharmacoepidemiology #Transparency #OpenScience
Discover how a proposed transparency statement can advance openness and reproducibility in research in our latest guest blog post from @antonpottegaard.bsky.social and @shirleywangv.bsky.social.
#Pharmacoepidemiology #Transparency #OpenScience
Transparency in pharmacoepidemiology research: a call to action
Pharmacoepidemiology is at a crossroads. With the increasing availability of large healthcare datasets, transparent research practices are essential for maintaining trust and ensuring scientific valid...
www.openpharma.blog
May 13, 2025 at 11:32 AM
Pharmacoepidemiology is at a crossroads 🛣️
Discover how a proposed transparency statement can advance openness and reproducibility in research in our latest guest blog post from @antonpottegaard.bsky.social and @shirleywangv.bsky.social.
#Pharmacoepidemiology #Transparency #OpenScience
Discover how a proposed transparency statement can advance openness and reproducibility in research in our latest guest blog post from @antonpottegaard.bsky.social and @shirleywangv.bsky.social.
#Pharmacoepidemiology #Transparency #OpenScience
Reposted by DIAMOND Research Programme
Join the next Int. Deprescribing Journal Club session on May 23rd!
The next International Deprescribing Journal Club is May 23rd!
The German Deprescribing Network will be hosting Dr. Karen Voigt, who will discuss facilitators & barriers to #deprescribing levothyroxine, and strategies to engage patients & physicians.
Register here: us02web.zoom.us/meeting/regi...
The German Deprescribing Network will be hosting Dr. Karen Voigt, who will discuss facilitators & barriers to #deprescribing levothyroxine, and strategies to engage patients & physicians.
Register here: us02web.zoom.us/meeting/regi...
May 9, 2025 at 4:30 PM
Join the next Int. Deprescribing Journal Club session on May 23rd!
Reposted by DIAMOND Research Programme
🚨ICYMI - Updated Cochrane #SystematicReview:
Withdrawal of antihypertensive drugs in older people 💊
doi.org/10.1002/1465...
"Future research should focus on populations with the greatest uncertainty of the benefit:risk ratio"
#CochraneEvidence #bloodpressure #deprescribing
Withdrawal of antihypertensive drugs in older people 💊
doi.org/10.1002/1465...
"Future research should focus on populations with the greatest uncertainty of the benefit:risk ratio"
#CochraneEvidence #bloodpressure #deprescribing
May 12, 2025 at 6:09 PM
🚨ICYMI - Updated Cochrane #SystematicReview:
Withdrawal of antihypertensive drugs in older people 💊
doi.org/10.1002/1465...
"Future research should focus on populations with the greatest uncertainty of the benefit:risk ratio"
#CochraneEvidence #bloodpressure #deprescribing
Withdrawal of antihypertensive drugs in older people 💊
doi.org/10.1002/1465...
"Future research should focus on populations with the greatest uncertainty of the benefit:risk ratio"
#CochraneEvidence #bloodpressure #deprescribing
Reposted by DIAMOND Research Programme
It’s official: we are partnering with @deprescribeus.bsky.social to welcome you in Montréal for the next International Conference on Deprescribing!
Mark your calendars for Apr 27-29, 2026!
Follow us to stay informed about ICOD2026, including the call for abstracts and registration details.
Mark your calendars for Apr 27-29, 2026!
Follow us to stay informed about ICOD2026, including the call for abstracts and registration details.
May 7, 2025 at 6:44 PM
It’s official: we are partnering with @deprescribeus.bsky.social to welcome you in Montréal for the next International Conference on Deprescribing!
Mark your calendars for Apr 27-29, 2026!
Follow us to stay informed about ICOD2026, including the call for abstracts and registration details.
Mark your calendars for Apr 27-29, 2026!
Follow us to stay informed about ICOD2026, including the call for abstracts and registration details.
Reposted by DIAMOND Research Programme
ICYMI - #Deprescribing webinar recording! 😍
When making decisions about 🛑#statins, consider:
✅pt values, preferences
✅health status
✅current evidence
Watch as the TI's Dr. Wade Thompson summarizes current evidence: tiny.cc/StatinDepres...
When making decisions about 🛑#statins, consider:
✅pt values, preferences
✅health status
✅current evidence
Watch as the TI's Dr. Wade Thompson summarizes current evidence: tiny.cc/StatinDepres...
Dr. Wade Thompson: Statin deprescribing for older adults
YouTube video by Therapeutics Initiative
www.youtube.com
May 1, 2025 at 6:56 PM
ICYMI - #Deprescribing webinar recording! 😍
When making decisions about 🛑#statins, consider:
✅pt values, preferences
✅health status
✅current evidence
Watch as the TI's Dr. Wade Thompson summarizes current evidence: tiny.cc/StatinDepres...
When making decisions about 🛑#statins, consider:
✅pt values, preferences
✅health status
✅current evidence
Watch as the TI's Dr. Wade Thompson summarizes current evidence: tiny.cc/StatinDepres...
Reposted by DIAMOND Research Programme
Great article detailing the life-cycle of medications and all the greenhouse gas (GHG) emissions that are produced along the way:
www.cfp.ca/content/71/4...
#Deprescribing is one of the easiest and most cost-effective strategies to reduce healthcare emissions!
@peachhealthon.bsky.social
www.cfp.ca/content/71/4...
#Deprescribing is one of the easiest and most cost-effective strategies to reduce healthcare emissions!
@peachhealthon.bsky.social
April 18, 2025 at 4:03 PM
Great article detailing the life-cycle of medications and all the greenhouse gas (GHG) emissions that are produced along the way:
www.cfp.ca/content/71/4...
#Deprescribing is one of the easiest and most cost-effective strategies to reduce healthcare emissions!
@peachhealthon.bsky.social
www.cfp.ca/content/71/4...
#Deprescribing is one of the easiest and most cost-effective strategies to reduce healthcare emissions!
@peachhealthon.bsky.social
The DIAMOND team are preparing our submissions! Looking forward to meeting you all there! #deprescribing
Planning for ICOD3 has launched! 🚀
The ICOD3 planning committee met for the 1st time to brainstorm vision & objectives for the meeting, to be held in Spring 2026 in Canada and co-hosted by CADeN & @deprescribeus.bsky.social.
Stay tuned for more info: official dates and venue are coming soon! 👀
The ICOD3 planning committee met for the 1st time to brainstorm vision & objectives for the meeting, to be held in Spring 2026 in Canada and co-hosted by CADeN & @deprescribeus.bsky.social.
Stay tuned for more info: official dates and venue are coming soon! 👀
April 25, 2025 at 8:38 AM
The DIAMOND team are preparing our submissions! Looking forward to meeting you all there! #deprescribing
Reposted by DIAMOND Research Programme
I can’t wait for the 3rd International Conference on Deprescribing and am thrilled to be part of this incredible planning committee! 💊
Stay tuned for more updates!
Stay tuned for more updates!
Planning for ICOD3 has launched! 🚀
The ICOD3 planning committee met for the 1st time to brainstorm vision & objectives for the meeting, to be held in Spring 2026 in Canada and co-hosted by CADeN & @deprescribeus.bsky.social.
Stay tuned for more info: official dates and venue are coming soon! 👀
The ICOD3 planning committee met for the 1st time to brainstorm vision & objectives for the meeting, to be held in Spring 2026 in Canada and co-hosted by CADeN & @deprescribeus.bsky.social.
Stay tuned for more info: official dates and venue are coming soon! 👀
March 19, 2025 at 3:12 PM
I can’t wait for the 3rd International Conference on Deprescribing and am thrilled to be part of this incredible planning committee! 💊
Stay tuned for more updates!
Stay tuned for more updates!
Agreed! DIAMOND aims to producing robust re-usable tools and resources for deprescribing research by advancing novel methods for harnessing big data. Watch this space: diamond-deprescribing.eu
April 25, 2025 at 8:36 AM
Agreed! DIAMOND aims to producing robust re-usable tools and resources for deprescribing research by advancing novel methods for harnessing big data. Watch this space: diamond-deprescribing.eu
Reposted by DIAMOND Research Programme
CP3's @timandersonmd.bsky.social & team discuss the importance of avoiding tunnel vision in recognizing harms in #deprescribing trials.
Read more in @agsjournal.bsky.social:
agsjournals.onlinelibrary.wiley.com/doi/10.1111/...
Read more in @agsjournal.bsky.social:
agsjournals.onlinelibrary.wiley.com/doi/10.1111/...
April 24, 2025 at 12:59 PM
CP3's @timandersonmd.bsky.social & team discuss the importance of avoiding tunnel vision in recognizing harms in #deprescribing trials.
Read more in @agsjournal.bsky.social:
agsjournals.onlinelibrary.wiley.com/doi/10.1111/...
Read more in @agsjournal.bsky.social:
agsjournals.onlinelibrary.wiley.com/doi/10.1111/...
Reposted by DIAMOND Research Programme
SR & MA findings: very few (<10%) clinical trials report adverse drug withdrawal event (ADWE) following #deprescribing, and reporting methods are inconsistent.
Standardizing reporting is needed to generate more robust evidence on deRXing and ADWEs: agsjournals.onlinelibrary.wiley.com/doi/10.1111/...
Standardizing reporting is needed to generate more robust evidence on deRXing and ADWEs: agsjournals.onlinelibrary.wiley.com/doi/10.1111/...
April 15, 2025 at 1:34 PM
SR & MA findings: very few (<10%) clinical trials report adverse drug withdrawal event (ADWE) following #deprescribing, and reporting methods are inconsistent.
Standardizing reporting is needed to generate more robust evidence on deRXing and ADWEs: agsjournals.onlinelibrary.wiley.com/doi/10.1111/...
Standardizing reporting is needed to generate more robust evidence on deRXing and ADWEs: agsjournals.onlinelibrary.wiley.com/doi/10.1111/...
Reposted by DIAMOND Research Programme
Over the past year, CADeN has developed powerful testimonials to raise awareness of med. overload, #deprescribing, and to encourage discussions between patients, caregivers and HCPs.
Discover Frances, Micheline, Laurent and Yves' stories here: www.deprescribingnetwork.ca/testimonials
Discover Frances, Micheline, Laurent and Yves' stories here: www.deprescribingnetwork.ca/testimonials
April 14, 2025 at 4:54 PM
Over the past year, CADeN has developed powerful testimonials to raise awareness of med. overload, #deprescribing, and to encourage discussions between patients, caregivers and HCPs.
Discover Frances, Micheline, Laurent and Yves' stories here: www.deprescribingnetwork.ca/testimonials
Discover Frances, Micheline, Laurent and Yves' stories here: www.deprescribingnetwork.ca/testimonials
Great 2nd DIAMOND Steering Group meeting today on #WorldHealthDay, bringing together diverse expertise in:
📈 Biostatistics & Data Science
🏥 Health Services Research & GP
💊 Pharmacy & Pharmacoepidemiology
🗣️ Patient & Public Involvement
Details here: diamond-deprescribing.eu/team/. #HopefulFutures
📈 Biostatistics & Data Science
🏥 Health Services Research & GP
💊 Pharmacy & Pharmacoepidemiology
🗣️ Patient & Public Involvement
Details here: diamond-deprescribing.eu/team/. #HopefulFutures
April 7, 2025 at 7:46 PM
Great 2nd DIAMOND Steering Group meeting today on #WorldHealthDay, bringing together diverse expertise in:
📈 Biostatistics & Data Science
🏥 Health Services Research & GP
💊 Pharmacy & Pharmacoepidemiology
🗣️ Patient & Public Involvement
Details here: diamond-deprescribing.eu/team/. #HopefulFutures
📈 Biostatistics & Data Science
🏥 Health Services Research & GP
💊 Pharmacy & Pharmacoepidemiology
🗣️ Patient & Public Involvement
Details here: diamond-deprescribing.eu/team/. #HopefulFutures